Table 1

Study population description

Controls (n = 1057)

Gleason 6 PC (n = 402)

Gleason 7 PC (n = 272)

Gleason 8-10 PC (n = 135)

Median

25th-75th

Median

25th-75th

Median

25th-75th

Median

25th-75th

p*


Age (years)

64.0

58.0-70.0

64.5

59.0-70.0

66.0

61.0-72.0

69.0

64.0-75.0

< 0.01

PSA (ng/ml)

5.0

4.0-6.8

5.0

4.2-6.7

6.0

4.6-8.4

8.0

5.5-16.4

< 0.01

Prostate Volume (ml)

45.1

33.3-62.8

37.7

28.2-53.0

33.0

25.8-45.0

35.6

26.1-49.6

< 0.01

n

%

n

%

n

%

n

%


Non-white ethnicity

103

9.7%

50

12.4%

38

13.9%

14

10.3%

0.17

Family History PC

215

20.3%

112

27.9%

58

21.3%

17

12.5%

< 0.01

Diabetes Tx

149

14.1%

50

12.4%

40

14.7%

22

16.3%

0.68

CVD Tx

591

55.9%

244

60.7%

171

62.9%

77

57.0%

0.12

BPH Tx

210

19.9%

74

18.4%

44

16.2%

16

11.9%

0.10

Hyperlipidemia Tx

436

41.3%

180

44.8%

121

55.5%

60

44.4%

0.54


P value from Chi-Square or Kruskal-Wallis test

Fowke et al. BMC Cancer 2012 12:23   doi:10.1186/1471-2407-12-23

Open Data